Clinical Trials Related to Neuroblastoma

Related studies linked through entity extraction aliases.

A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors

Status: TERMINATED
Phase: PHASE1/PHASE2

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

Status: TERMINATED
Phase: PHASE1/PHASE2

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Status: UNKNOWN
Phase: N/A

A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

Status: COMPLETED
Phase: PHASE1

Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers

Status: TERMINATED
Phase: PHASE1/PHASE2

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Status: RECRUITING
Phase: PHASE1

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]

Status: COMPLETED
Phase: N/A

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

DOTATOC PET/CT for Imaging NET Patients

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

An Intermediate Expanded Use Trial of DFMO

Status: AVAILABLE
Phase: N/A

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

Status: UNKNOWN
Phase: PHASE2

Investigating the Microbiome and Volatile Organic Compound Profile of Children With Neuroblastoma

Status: UNKNOWN
Phase: NA

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

Status: ACTIVE_NOT_RECRUITING
Phase: EARLY_PHASE1

Nutritional Status in Neuroblastoma in Sao Paolo, Brazil

Status: COMPLETED
Phase: N/A

Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

Status: ACTIVE_NOT_RECRUITING
Phase: NA

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients

Status: TERMINATED
Phase: PHASE1/PHASE2

International PPB/DICER1 Registry

Status: RECRUITING
Phase: N/A